Advertisement
NTRA vs WGS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTRA is a StrongBuy and WGS is a Hold.
Aroon Indicator for NTRA shows an upward move is likely
NTRA's Aroon Indicator triggered a bullish signal on October 15, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 286 similar instances where the Aroon Indicator showed a similar pattern. In 231 of the 286 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 81%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on NTRA as a result. In 77 of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.
Following a +0.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where NTRA advanced for three days, in 245 of 308 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
Bearish Trend Analysis
The 10-day RSI Indicator for NTRA moved out of overbought territory on October 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 24 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 63%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 47 of 65 cases where NTRA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 72%.
The Moving Average Convergence Divergence Histogram (MACD) for NTRA turned negative on October 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 31 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 62%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NTRA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
NTRA broke above its upper Bollinger Band on September 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (32.042) is normal, around the industry mean (65.624). NTRA's P/E Ratio (-299.926) is considerably lower than the industry average of (2.414). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (17.857) is also within normal values, averaging (9.775).
The Tickeron Profit vs. Risk Rating rating for this company is 7 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. NTRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 91 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
WGS sees its 50-day moving average cross bullishly above its 200-day moving average
The 50-day moving average for WGS moved above the 200-day moving average on September 28, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where WGS's RSI Indicator exited the oversold zone, 29 of 37 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +4.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where WGS advanced for three days, in 234 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
WGS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on WGS as a result. In 72 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for WGS turned negative on October 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 40 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 87%.
WGS moved below its 50-day moving average on September 29, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for WGS crossed bearishly below the 50-day moving average on October 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 89%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where WGS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for WGS entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 33 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.481) is normal, around the industry mean (65.624). P/E Ratio (-16.876) is within average values for comparable stocks, (2.414). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (6.270) is also within normal values, averaging (9.775).
The Tickeron Price Growth Rating for this company is 82 (best 1 - 100 worst), indicating slightly worse than average price growth. WGS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WGS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
NTRA | WGS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 83 | 8 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 6 Undervalued | 33 Fair valued | |
PROFIT vs RISK RATING 1..100 | 7 | 100 | |
SMR RATING 1..100 | 94 | 97 | |
PRICE GROWTH RATING 1..100 | 35 | 82 | |
P/E GROWTH RATING 1..100 | 91 | 97 | |
SEASONALITY SCORE 1..100 | 85 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NTRA's Valuation (6) in the Biotechnology industry is in the same range as WGS (33) in the null industry. This means that NTRA’s stock grew similarly to WGS’s over the last 12 months.
NTRA's Profit vs Risk Rating (7) in the Biotechnology industry is significantly better than the same rating for WGS (100) in the null industry. This means that NTRA’s stock grew significantly faster than WGS’s over the last 12 months.
NTRA's SMR Rating (94) in the Biotechnology industry is in the same range as WGS (97) in the null industry. This means that NTRA’s stock grew similarly to WGS’s over the last 12 months.
NTRA's Price Growth Rating (35) in the Biotechnology industry is somewhat better than the same rating for WGS (82) in the null industry. This means that NTRA’s stock grew somewhat faster than WGS’s over the last 12 months.
NTRA's P/E Growth Rating (91) in the Biotechnology industry is in the same range as WGS (97) in the null industry. This means that NTRA’s stock grew similarly to WGS’s over the last 12 months.
| NTRA | WGS | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 63% | 1 day ago 78% |
| Stochastic ODDS (%) | 1 day ago 72% | 1 day ago 83% |
| Momentum ODDS (%) | 1 day ago 78% | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 62% | 1 day ago 87% |
| TrendWeek ODDS (%) | 1 day ago 82% | 1 day ago 89% |
| TrendMonth ODDS (%) | 1 day ago 79% | 1 day ago 90% |
| Advances ODDS (%) | 1 day ago 80% | 6 days ago 85% |
| Declines ODDS (%) | 13 days ago 76% | 4 days ago 85% |
| BollingerBands ODDS (%) | 5 days ago 58% | 1 day ago 85% |
| Aroon ODDS (%) | 1 day ago 81% | 1 day ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
NTRA’s FA Score shows that 2 FA rating(s) are green while WGS’s FA Score has 1 green FA rating(s).
- NTRA’s FA Score: 2 green, 3 red.
- WGS’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
NTRA’s TA Score shows that 3 TA indicator(s) are bullish while WGS’s TA Score has 5 bullish TA indicator(s).
- NTRA’s TA Score: 3 bullish, 5 bearish.
- WGS’s TA Score: 5 bullish, 6 bearish.
Price Growth
NTRA (@Medical Specialties) experienced а +1.37% price change this week, while WGS (@Medical Specialties) price change was -7.59% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +2.15%. For the same industry, the average monthly price growth was -8.18%, and the average quarterly price growth was +49.55%.
Reported Earning Dates
NTRA is expected to report earnings on Nov 05, 2026.
WGS is expected to report earnings on Oct 27, 2026.
Industries' Descriptions
@Medical Specialties (+2.15% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
Advertisement
WGS and
Correlation & Price change
A.I.dvisor indicates that over the last year, WGS has been loosely correlated with COIN. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if WGS jumps, then COIN could also see price increases.
| Ticker / NAME | Correlation To WGS | 1D Price Change % | ||
|---|---|---|---|---|
| WGS | 100% | +9.10% | ||
| COIN - WGS | 59% Loosely correlated | -2.95% | ||
| CLSK - WGS | 53% Loosely correlated | -1.40% | ||
| RIOT - WGS | 50% Loosely correlated | +0.48% | ||
| NTRA - WGS | 37% Loosely correlated | +0.24% | ||
| ADPT - WGS | 37% Loosely correlated | +2.98% | ||
More | ||||